Key result
Higher serum MDA-LDL is linked to NAFLD and high-risk coronary plaques.
Why the study?
NAFLD is a risk factor for atherosclerotic CVDs with oxidative stress proposed as a shared pathophysiological condition, but whether oxidized LDL links coronary atherosclerosis and NAFLD remained to be examined.
Is oxidized LDL associated with the presence of high-risk coronary plaques in patients with NAFLD?
Case-Control (n=300)
Is oxidized LDL associated with the presence of high-risk coronary plaques in patients with NAFLD?
Effect estimate: β = 11.337
p-value: p=0.005
Increased oxidized LDL (MDA-LDL) may mediate the relationship between NAFLD and the development of high-risk coronary plaques.
May implicate MDA-LDL mediation between NAFLD and high-risk plaques; hypothesis-generating, needs prospective confirmation.
Nonalcoholic fatty liver disease (NAFLD) is a risk factor for the development of atherosclerotic cardiovascular diseases (CVDs), and oxidative stress has been proposed as a shared pathophysiological condition. This study examined whether oxidized low-density lipoprotein (LDL) is involved in the underlying mechanism that links coronary atherosclerosis and NAFLD. This study included 631 patients who underwent coronary computed tomography angiography (CTA) for suspected coronary artery disease. NAFLD was defined on CT images as a liver-to-spleen attenuation ratio of <1.0. Serum-malondialdehyde-modified LDL (MDA-LDL) and coronary CTA findings were analyzed in a propensity-score-matched cohort of patients with NAFLD (n = 150) and those without NAFLD (n = 150). This study analyzed 300 patients (median age, 65 years; 64% men). Patients with NAFLD had higher MDA-LDL levels and a greater presence of CTA-verified high-risk plaques than those without NAFLD. In the multivariate linear regression analysis, MDA-LDL was independently associated with NAFLD (β = 11.337, p = 0.005) and high-risk plaques (β = 12.487, p = 0.007). Increased MDA-LDL may be a mediator between NAFLD and high-risk coronary plaque on coronary CTA. Increased oxidative stress in NAFLD, as assessed using MDA-LDL, may be involved in the development of CVDs.
No takes yet. Share an insight, caveat, or question.
Nishihara et al. (2022) conducted a case-control in Suspected coronary artery disease (n=300). Nonalcoholic fatty liver disease (NAFLD) vs. Without NAFLD was evaluated on Serum-malondialdehyde-modified LDL (MDA-LDL) levels (β = 11.337, p=0.005). Serum-malondialdehyde-modified LDL was independently associated with nonalcoholic fatty liver disease (β = 11.337, p = 0.005) and high-risk coronary plaques (β = 12.487, p = 0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: